GLP-1 maintenance patients have different needs than new starters. You've completed the titration phase, your dose is stable, and your clinical interactions are simpler — primarily regular refills, occasional dose check-ins, and long-term weight maintenance support. The questions that mattered at enrollment (how quickly can I get started? what if my dose needs adjustment frequently?) matter less now.
What matters at maintenance: predictable monthly cost at your stable dose, reliable auto-refill cadence without gaps, a pharmacy you can independently verify, and a clinical model that supports long-term treatment without requiring constant re-engagement. These are the criteria that determine whether Fridays or an alternative is better for your next 12 to 24 months.
What Maintenance GLP-1 Patients Actually Need
💰 Predictable monthly cost — the same price every month
At maintenance you know your dose won't change dramatically. Dose-tier pricing structures that increase with dose are no longer the concern — you need to know exactly what you'll pay this month, next month, and the month after that.
📦 Reliable auto-refill with no manual re-ordering
A consistent medication supply without effort from you. Gaps in weekly semaglutide or tirzepatide injections during maintenance lead to weight regain (STEP 4 data). Auto-ship reliability is the single most important operational factor at this stage.
📋 Publicly named, verifiable pharmacy
At maintenance you've built trust in the process — but for an injectable medication you'll be using for 2+ years, knowing your pharmacy's independent regulatory credentials matters more than during the initial enrollment urgency.
⚡ Simple clinical oversight — no unnecessary check-in friction
Maintenance doesn't require intensive provider contact. Monthly billing, quarterly or semi-annual prescription renewals, and easy messaging access for questions is the appropriate clinical model. You don't need or want intensive re-engagement at stable doses.
How Fridays Performs Against Maintenance Patient Needs
Fridays at Maintenance: Criterion-by-Criterion
Better Maintenance Alternatives to Fridays
Long-Term Cost Comparison: Fridays vs Alternatives at Maintenance
At maintenance you're looking at years of treatment, not months. The annual cost difference between platforms compounds meaningfully over a 2–3 year treatment horizon. Assuming $X/month at Fridays (verify current rate at getfridays.com) vs alternatives:
| Platform | Sema (Maintenance) | Tirz (Maintenance) | Pharmacy Named | Annual Commitment |
|---|---|---|---|---|
| Fridays | Verify at getfridays.com | Verify at getfridays.com | Not prominently | Verify |
| Henry Meds | ~$89–$149/mo (annual) | ~$179/mo flat (annual) | Not prominently | Yes — annual required |
| ★ Luma Health | $197/mo flat | $297/mo flat | ✓ VialsRX TX#35264 | None — cancel anytime |
| Ro Body | ~$199–$229/mo | ~$299–$329/mo | Ro-owned (named) | None |
| Hims | ~$149–$199/mo | ~$249–$329/mo | Not prominently | None |
How to Switch From Fridays to Luma Health Without a Gap
Confirm your current dose and medication
Note your current medication (semaglutide or tirzepatide), weekly dose, and how long you've been stable at this dose. Take a photo of your current vial label. At maintenance your dose is stable — your new provider prescribes the same dose, no restart needed.
Start Luma Health intake with 2–3 doses remaining
Visit start.mylumahealth.com while you still have 2 to 3 weeks of Fridays medication remaining. The intake takes 10–15 minutes. Specify your current dose. Wasef Health, PC reviews within 24–48 hours and prescribes at your current maintenance dose.
Wait for VialsRX tracking confirmation
VialsRX ships within 5–10 business days of prescription approval. You receive a tracking email. Do not cancel Fridays until this tracking number arrives — ideally until the medication is in hand.
Cancel Fridays and continue at your maintenance dose
Cancel your Fridays subscription through their account settings and request written confirmation of the effective date. On your next injection day, inject your maintenance dose from the VialsRX vial. No adjustment, no re-titration. Same active molecule, same weekly schedule.
Frequently Asked Questions
Why would I switch from Fridays at maintenance when I'm already stable?
The most common reasons maintenance patients consider switching from Fridays are: (1) wanting an independently verifiable named pharmacy — at maintenance you're committing to 12–24 more months of injectable medication from a specific pharmacy, and Fridays doesn't prominently name theirs for independent verification; (2) wanting flat-rate pricing certainty — if Fridays has any dose-tier pricing components, maintenance patients benefit from a platform that guarantees the same price regardless of dose; (3) cost — verify whether Fridays' current maintenance rate is higher than alternatives like Luma Health ($197/mo flat) or Henry Meds ($89–$149/mo annual). Stability itself isn't a reason not to switch — the question is whether the switch improves your long-term value without creating a treatment gap.
Will switching providers at maintenance affect my weight loss results?
No — as long as you continue weekly injections at your current maintenance dose without a gap. Your weight loss results are maintained by continuous GLP-1 receptor activation at your stable dose. STEP 4 data (Rubino et al., JAMA 2021) confirmed this clearly: patients who continued semaglutide treatment maintained their weight loss results, while patients who discontinued regained most of the lost weight over the following year. What matters is medication continuity — not which platform's name is on the prescription.
What is Fridays' compounding pharmacy?
Fridays (getfridays.com) does not prominently name its compounding pharmacy in consumer-facing materials. To obtain this information, contact Fridays support directly and ask for the compounding pharmacy's name and state board license number. This is a reasonable question for any patient using an injectable compounded medication for long-term treatment. For comparison, Luma Health publicly names VialsRX (Texas State Board license #35264) — independently verifiable at pharmacy.texas.gov before enrolling and at any point during treatment.
How does Luma Health's maintenance pricing compare to Fridays?
Fridays' specific maintenance pricing should be verified directly at getfridays.com — rates change periodically and the comparison depends on your current dose tier. Luma Health charges $197/month for semaglutide and $297/month for tirzepatide at every dose from starting through maintenance — a flat rate that never increases. To make the direct comparison: check your current Fridays monthly charge at your stable maintenance dose against Luma Health's $197/month flat. If Fridays is lower, stay for cost reasons while considering the pharmacy transparency gap. If Fridays is comparable or higher, the switch to Luma Health provides flat-rate predictability and named pharmacy access at no additional cost.
Is Fridays a legitimate platform for long-term GLP-1 treatment?
Yes. Fridays uses US-licensed clinicians and FDA-regulated 503A compounding pharmacies. The compounded semaglutide and tirzepatide they prescribe use the same active pharmaceutical molecules as brand-name approved drugs. The pharmacy transparency limitation (pharmacy not prominently named) is a service model gap rather than a safety concern. Fridays is a legitimate platform; the question for long-term maintenance patients is whether an alternative provides better value across the 2+ year treatment horizon they're now committed to.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
- Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28:2083–2091. PubMed
- Aronne LJ, et al. Continued Treatment with Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4). JAMA. 2024;331(1):38–48. PubMed
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- Fridays. Official Website. getfridays.com
- Texas State Board of Pharmacy. License Verification. pharmacy.texas.gov
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov